Nuclear Factor-ĸb Plays a Critical Role in Both Intrinsic and Acquired Resistance Against Endocrine Therapy in Human Breast Cancer Cells

Scientific Reports - United Kingdom
doi 10.1038/srep04057
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2010English

D538G Mutation in Estrogen Receptor- : A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer

Cancer Research
Cancer ResearchOncology
2013English

Neoadjuvant Endocrine Therapy in Breast Cancer: Current Role and Future Perspectives

ecancermedicalscience
Cancer ResearchOncology
2016English

Predicting Response/Resistance to Endocrine Therapy for Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2005English

Angiocidin Inhibits Breast Cancer Proliferation Through Activation of Epidermal Growth Factor Receptor and Nuclear Factor Kappa (NF-ĸB)

Experimental and Molecular Pathology
Forensic MedicinePathologyClinical BiochemistryMolecular Biology
2011English

Mechanisms of Acquired Resistance to Trastuzumab Emtansine in Breast Cancer Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Endocrine Therapy of Breast Cancer

2008English

Exome Sequencing Identifies Somatic Point Mutations Associated With Acquired Endocrine Resistance in Breast Cancer Cell Lines

BMC Proceedings
BiochemistryMedicineGeneticsMolecular Biology
2012English

Endocrinology and Hormone Therapy in Breast Cancer: New Insight Into Estrogen Receptor-Α Function and Its Implication for Endocrine Therapy Resistance in Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy